U.S. News compares companies to their industry peers based on a variety of company fundamentals, performance metrics and investor preferences to help you find the right stocks for your investing style. Cognition Therapeutics Inc is listed as: Safe(er) Stock in category See all Best Stocks lists...
$CGTX stock has now risen 17% today, according to our price data from Polygon. There has been approximately $20,818,545 of trading volume.
A high-level overview of American Funds 2040 Target Date Retirement Fund® C (CCGTX) stock. View (CCGTX) real-time stock price, chart, news, analysis, analyst reviews and more.
Get Cognition Therapeutics Inc (CGTX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
A high-level overview of Transamerica Small Cap Growth C (CSGTX) stock. View (CSGTX) real-time stock price, chart, news, analysis, analyst reviews and more.
quotes Price Overview Performance Report charts Interactive Chart Snapshot Chart technicals Barchart Opinion Trading Strategies Top Trade Alerts Technical Analysis Trader's Cheat Sheet Seasonal Returns Price History Historical Data company News & Headlines Key Statistics SEC Filings Stock Comparison Insider ...
智通财经APP获悉,7月29日,生物制药公司Cognition Therapeutics(CGTX.US)公布了概念性验证(Proof of Concept)2期“SHINE”研究,结果显示其每日一次的实验性口服药物CT1812对轻至中度阿尔茨海默病患者的认知结果持续改善。 SHINE是一项双盲、安慰剂对照的2期临床试验,招募了153名患有轻至中度阿尔茨海默病成年患者。参与...
在前面的三个月中,5位分析师对TG Therapeutics (纳斯达克:TGTX)发布了评级,呈现出从看好到看淡的广泛观点。以下表格概括了 Benzinga01/15 20:00 tg therapeutics分析师评级 日期upside/downside 分析师 公司 价格目标 变更 评级变更 之前/当前评级 01/15/2025 86.44% HC Wainwright & Co. $55 → $55 重申 买...
Recent News MarketWatch Dow Jones Cognition Therapeutics’ stock tumbles as trial of oral treatment for mild to moderate Alzheimer’s disease misses key efficacy goal Jul. 29, 2024 at 11:28 a.m. ET by Ciara Linnane Cognition Therapeutics stock price target cut to $15 from $20 at B....
Recent News Cognition Therapeutics’ stock tumbles as trial of oral treatment for mild to moderate Alzheimer’s disease misses key efficacy goal Jul. 29, 2024 at 11:28 a.m. ETby Ciara Linnane Cognition Therapeutics stock price target cut to $15 from $20 at B. Riley ...